Advertisement

The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2

Published:August 22, 2022DOI:https://doi.org/10.1016/j.gim.2022.07.020

      Abstract

      Purpose

      Postzygotic (somatic) variants in the mTOR pathway genes cause a spectrum of distinct developmental abnormalities. Accurate classification of somatic variants in this group of disorders is crucial for affected individuals and their families.

      Methods

      The ClinGen Brain Malformation Variant Curation Expert Panel was formed to curate somatic variants associated with developmental brain malformations. We selected the genes AKT3, MTOR, PIK3CA, and PIK3R2 as the first set of genes to provide additional specifications to the 2015 American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP) sequence variant interpretation guidelines, which currently focus solely on germline variants.

      Results

      A total of 24 of the original 28 ACMG/AMP criteria required modification. Several modifications used could be applied to other genes and disorders in which somatic variants play a role: 1) using variant allele fraction differences as evidence that somatic mutagenesis occurred as a proxy for de novo variation, 2) incorporating both somatic and germline evidence, and 3) delineating phenotype on the basis of variable tissue expression.

      Conclusion

      We have established a framework for rigorous interpretation of somatic mosaic variants, addressing issues unique to somatic variants that will be applicable to many genes and conditions.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.

      Subscribe:

      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Barkovich A.J.
        • Guerrini R.
        • Kuzniecky R.I.
        • Jackson G.D.
        • Dobyns W.B.
        A developmental and genetic classification for malformations of cortical development: update 2012.
        Brain. 2012; 135: 1348-1369https://doi.org/10.1093/brain/aws019
        • Severino M.
        • Geraldo A.F.
        • Utz N.
        • et al.
        Definitions and classification of malformations of cortical development: practical guidelines.
        Brain. 2020; 143 (Published correction appears in Brain. 2020;143(12):e108.): 2874-2894
        • Poduri A.
        • Evrony G.D.
        • Cai X.
        • et al.
        Somatic activation of AKT3 causes hemispheric developmental brain malformations.
        Neuron. 2012; 74: 41-48https://doi.org/10.1016/j.neuron.2012.03.010
        • Lee J.H.
        • Huynh M.
        • Silhavy J.L.
        • et al.
        De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
        Nat Genet. 2012; 44: 941-945https://doi.org/10.1038/ng.2329
        • Murugan A.K.
        • Alzahrani A.
        • Xing M.
        Mutations in critical domains confer the human mTOR gene strong tumorigenicity.
        J Biol Chem. 2013; 288: 6511-6521https://doi.org/10.1074/jbc.M112.399485
        • Rivière J.B.
        • Mirzaa G.M.
        • O’Roak B.J.
        • et al.
        De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.
        Nat Genet. 2012; 44: 934-940https://doi.org/10.1038/ng.2331
        • D’Gama A.M.
        • Woodworth M.B.
        • Hossain A.A.
        • et al.
        Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias.
        Cell Rep. 2017; 21: 3754-3766https://doi.org/10.1016/j.celrep.2017.11.106
        • Mirzaa G.
        • Timms A.E.
        • Conti V.
        • et al.
        PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution.
        JCI Insight. 2016; 1e87623https://doi.org/10.1172/jci.insight.87623
        • Jiang N.
        • Dai Q.
        • Su X.
        • Fu J.
        • Feng X.
        • Peng J.
        Role of PI3K/AKT pathway in cancer: the framework of malignant behavior.
        Mol Biol Rep. 2020; 47: 4587-4629https://doi.org/10.1007/s11033-020-05435-1
        • Liu S.
        • Knapp S.
        • Ahmed A.A.
        The structural basis of PI3K cancer mutations: from mechanism to therapy.
        Cancer Res. 2014; 74: 641-646https://doi.org/10.1158/0008-5472.CAN-13-2319
        • Parker V.E.R.
        • Keppler-Noreuil K.M.
        • Faivre L.
        • et al.
        Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum.
        Genet Med. 2019; 21: 1189-1198https://doi.org/10.1038/s41436-018-0297-9
        • Venot Q.
        • Blanc T.
        • Rabia S.H.
        • et al.
        Targeted therapy in patients with PIK3CA-related overgrowth syndrome.
        Nature. 2018; 558 (Published correction appears in Nature. 2019;568(7752):E6.): 540-546
        • Rehm H.L.
        • Berg J.S.
        • Brooks L.D.
        • et al.
        ClinGen—the Clinical Genome Resource.
        N Engl J Med. 2015; 372: 2235-2242https://doi.org/10.1056/NEJMsr1406261
        • Richards S.
        • Aziz N.
        • Bale S.
        • et al.
        Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
        Genet Med. 2015; 17: 405-424https://doi.org/10.1038/gim.2015.30
        • Pelle A.
        • Modena P.
        • Cavallini A.
        • Selicorni A.
        Haploinsufficiency of AKT3 gene causing microcephaly and psychomotor delay in a patient with 1q43q44 microdeletion.
        Clin Dysmorphol. 2020; 29: 97-100https://doi.org/10.1097/MCD.0000000000000313
        • Blesinger H.
        • Kaulfuß S.
        • Aung T.
        • et al.
        PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations.
        PLoS One. 2018; 13e0200343https://doi.org/10.1371/journal.pone.0200343
        • Kuentz P.
        • St-Onge J.
        • Duffourd Y.
        • et al.
        Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing.
        Genet Med. 2017; 19: 989-997https://doi.org/10.1038/gim.2016.220
        • Flanagan S.E.
        • Patch A.M.
        • Ellard S.
        Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations.
        Genet Test Mol Biomarkers. 2010; 14 (Published correction appears in Genet Test Mol Biomarkers. 2010;14(5):730.): 533-537
        • Biesecker L.G.
        • Harrison S.M.
        Clingen Sequence Variant Interpretation Working Group. The ACMG/AMP reputable source criteria for the interpretation of sequence variants.
        Genet Med. 2018; 20: 1687-1688https://doi.org/10.1038/gim.2018.42
        • Acuna-Hidalgo R.
        • Veltman J.A.
        • Hoischen A.
        New insights into the generation and role of de novo mutations in health and disease.
        Genome Biol. 2016; 17: 241https://doi.org/10.1186/s13059-016-1110-1
        • Rodin R.E.
        • Dou Y.
        • Kwon M.
        • et al.
        The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing.
        Nat Neurosci. 2021; 24 (Published correction appears in Nat Neurosci. 2021;24(4):611.): 176-185
      1. Biesecker LG, Sapp JC. Proteus syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews [Internet];1993-2022.

        • Spencer T.
        • Pan K.S.
        • Collins M.T.
        • Boyce A.M.
        The clinical spectrum of McCune-Albright syndrome and its management.
        Horm Res Paediatr. 2019; 92: 347-356https://doi.org/10.1159/000504802
        • Lim J.S.
        • Kim W.I.
        • Kang H.C.
        • et al.
        Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
        Nat Med. 2015; 21: 395-400https://doi.org/10.1038/nm.3824
        • Tian W.
        • Huang Y.
        • Sun L.
        • et al.
        Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants.
        Orphanet J Rare Dis. 2020; 15: 288https://doi.org/10.1186/s13023-020-01572-9
        • Quail M.A.
        • Smith M.
        • Coupland P.
        • et al.
        A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.
        BMC Genomics. 2012; 13: 341https://doi.org/10.1186/1471-2164-13-341
        • Grabiner B.C.
        • Nardi V.
        • Birsoy K.
        • et al.
        A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.
        Cancer Discov. 2014; 4: 554-563https://doi.org/10.1158/2159-8290.CD-13-0929
        • Bowman R.L.
        • Busque L.
        • Levine R.L.
        Clonal hematopoiesis and evolution to hematopoietic malignancies.
        Cell Stem Cell. 2018; 22: 157-170https://doi.org/10.1016/j.stem.2018.01.011
        • Bennett C.A.
        • Petrovski S.
        • Oliver K.L.
        • Berkovic S.F.
        ExACtly zero or once: A clinically helpful guide to assessing genetic variants in mild epilepsies.
        Neurol Genet. 2017; 3: e163https://doi.org/10.1212/NXG.0000000000000163
        • Brnich S.E.
        • Abou Tayoun A.N.
        • Couch F.J.
        • et al.
        Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.
        Genome Med. 2019; 12: 3https://doi.org/10.1186/s13073-019-0690-2
        • Terrone G.
        • Voisin N.
        • Abdullah Alfaiz A.
        • et al.
        De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia.
        Eur J Hum Genet. 2016; 24: 1359-1362https://doi.org/10.1038/ejhg.2016.7
        • Hardt M.
        • Chantaravisoot N.
        • Tamanoi F.
        Activating mutations of TOR (target of rapamycin).
        Genes Cells. 2011; 16: 141-151https://doi.org/10.1111/j.1365-2443.2010.01482.x
        • Alcantara D.
        • Timms A.E.
        • Gripp K.
        • et al.
        Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.
        Brain. 2017; 140: 2610-2622https://doi.org/10.1093/brain/awx203
        • Limaye N.
        • Kangas J.
        • Mendola A.
        • et al.
        Somatic activating PIK3CA mutations cause venous malformation.
        Am J Hum Genet. 2015; 97: 914-921https://doi.org/10.1016/j.ajhg.2015.11.011
        • Tavtigian S.V.
        • Harrison S.M.
        • Boucher K.M.
        • Biesecker L.G.
        Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines.
        Hum Mutat. 2020; 41: 1734-1737https://doi.org/10.1002/humu.24088
        • Møller R.S.
        • Weckhuysen S.
        • Chipaux M.
        • et al.
        Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy.
        Neurol Genet. 2016; 2: e118https://doi.org/10.1212/NXG.0000000000000118
        • Vranić S.
        • Bilalović N.
        • Lee L.M.
        • Kruslin B.
        • Lilleberg S.L.
        • Gatalica Z.
        PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney.
        Hum Pathol. 2007; 38: 1425-1431https://doi.org/10.1016/j.humpath.2007.03.021
        • Park J.S.
        • Lee J.
        • Jung E.S.
        • et al.
        Brain somatic mutations observed in Alzheimer’s disease associated with aging and dysregulation of tau phosphorylation.
        Nat Commun. 2019; 10: 3090https://doi.org/10.1038/s41467-019-11000-7
        • Rodin R.E.
        • Walsh C.A.
        Somatic mutation in pediatric neurological diseases.
        Pediatr Neurol. 2018; 87: 20-22https://doi.org/10.1016/j.pediatrneurol.2018.08.008